Cerebral lymphoma and steroids

The Kite death has reinforced the uncertainty around CAR-T therapies, which use live, genetically modified T cells, the attack soldiers of the immune system, to boost patients’ defenses against cancer. As Xconomy reported in March, doctors who treat leukemia and lymphoma are glad to have the first-generation CAR-Ts as a lifeline for patients with no options left . Large percentages of these patients have seen their cancer disappear, at least for a while, soon after treatment. In the case of KTE-C19, 36 percent of NHL patients had no sign of disease six months after treatment .

Cerebral lymphoma and steroids

cerebral lymphoma and steroids

Media:

cerebral lymphoma and steroidscerebral lymphoma and steroidscerebral lymphoma and steroidscerebral lymphoma and steroidscerebral lymphoma and steroids